메뉴 건너뛰기




Volumn 70, Issue 4, 2010, Pages 412-424

The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells

Author keywords

Bone metastasis; C4 2B; IL 6; MC3T3 E1; PC 3

Indexed keywords

INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; SOMATOMEDIN BINDING PROTEIN 5;

EID: 76149103234     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21075     Document Type: Article
Times cited : (30)

References (25)
  • 2
    • 24744439747 scopus 로고    scopus 로고
    • Prostate cancer cells promote osteoblastic bone metastases through Wnts
    • Hall CL, Bafico A, Dai J, Aaronson SA, Keller ET. Prostate cancer cells promote osteoblastic bone metastases through Wnts. Cancer Res 2005;65:7554-7560.
    • (2005) Cancer Res , vol.65 , pp. 7554-7560
    • Hall, C.L.1    Bafico, A.2    Dai, J.3    Aaronson, S.A.4    Keller, E.T.5
  • 3
    • 0027052350 scopus 로고
    • Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia
    • Bentley H, Hamdy FC, Hart KA, Seid JM, Williams JL, Johnstone D, Russell RG. Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia. Br J Cancer 1992;66:1159-1163.
    • (1992) Br J Cancer , vol.66 , pp. 1159-1163
    • Bentley, H.1    Hamdy, F.C.2    Hart, K.A.3    Seid, J.M.4    Williams, J.L.5    Johnstone, D.6    Russell, R.G.7
  • 4
    • 10744225879 scopus 로고    scopus 로고
    • Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein
    • Dai J, Kitagawa Y, Zhang J, Yao Z, Mizokami A, Cheng S, Nor J, McCauley LK, Taichman RS, Keller ET. Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein. Cancer Res 2004;64:994-999.
    • (2004) Cancer Res , vol.64 , pp. 994-999
    • Dai, J.1    Kitagawa, Y.2    Zhang, J.3    Yao, Z.4    Mizokami, A.5    Cheng, S.6    Nor, J.7    McCauley, L.K.8    Taichman, R.S.9    Keller, E.T.10
  • 5
    • 37749040562 scopus 로고    scopus 로고
    • Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF
    • Fujita K, Janz S. Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF. Mol Cancer 2007;6:71.
    • (2007) Mol Cancer , vol.6 , pp. 71
    • Fujita, K.1    Janz, S.2
  • 6
    • 0024404268 scopus 로고    scopus 로고
    • Lowik CW, van der Bloys H, Hoekman K, Bijvoet OL, Aarden LA, Papapoulos SE. Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesis. Biochem Biophys Res Commun 1989;162:1546-1552.
    • Lowik CW, van der PG, Bloys H, Hoekman K, Bijvoet OL, Aarden LA, Papapoulos SE. Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesis. Biochem Biophys Res Commun 1989;162:1546-1552.
  • 9
    • 0037195141 scopus 로고    scopus 로고
    • The osteopetrotic mutation toothless (tl) is a loss-of-function frameshift mutation in the rat Csf1 gene: Evidence of a crucial role for CSF-1 in osteoclastogenesis and endochondral ossification
    • Van WL, Odgren PR, MacKay CA, D'Angelo M, Safadi FF, Popoff SN, Van HW, Marks SC Jr. The osteopetrotic mutation toothless (tl) is a loss-of-function frameshift mutation in the rat Csf1 gene: Evidence of a crucial role for CSF-1 in osteoclastogenesis and endochondral ossification. Proc Natl Acad Sci USA 2002;99:14303-14308.
    • (2002) Proc Natl Acad Sci USA , vol.99 , pp. 14303-14308
    • Van, W.L.1    Odgren, P.R.2    MacKay, C.A.3    D'Angelo, M.4    Safadi, F.F.5    Popoff, S.N.6    Van, H.W.7    Marks Jr, S.C.8
  • 11
    • 32044447160 scopus 로고    scopus 로고
    • Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment
    • Brubaker KD, Brown LG, Vessella RL, Corey E. Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment. BMCCancer 2006;6:15.
    • (2006) BMCCancer , vol.6 , pp. 15
    • Brubaker, K.D.1    Brown, L.G.2    Vessella, R.L.3    Corey, E.4
  • 14
    • 0036604237 scopus 로고    scopus 로고
    • Establishment and characterization of osseous prostate cancer models: Intra-tibial injection of human prostate cancer cells
    • Corey E, Quinn JE, Bladou F, Brown LG, Roudier MP, Brown JM, Buhler KR, Vessella RL. Establishment and characterization of osseous prostate cancer models: Intra-tibial injection of human prostate cancer cells. Prostate 2002;52:20-33.
    • (2002) Prostate , vol.52 , pp. 20-33
    • Corey, E.1    Quinn, J.E.2    Bladou, F.3    Brown, L.G.4    Roudier, M.P.5    Brown, J.M.6    Buhler, K.R.7    Vessella, R.L.8
  • 15
    • 28244481510 scopus 로고    scopus 로고
    • Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity
    • Kitagawa Y, Dai J, Zhang J, Keller JM, Nor J, Yao Z, Keller ET. Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity. Cancer Res 2005;65: 10921-10929.
    • (2005) Cancer Res , vol.65 , pp. 10921-10929
    • Kitagawa, Y.1    Dai, J.2    Zhang, J.3    Keller, J.M.4    Nor, J.5    Yao, Z.6    Keller, E.T.7
  • 16
    • 34547657084 scopus 로고    scopus 로고
    • Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists
    • Ye L, Lewis-Russell JM, Kynaston H, Jiang WG. Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists. J Urol 2007;178:1086-1091.
    • (2007) J Urol , vol.178 , pp. 1086-1091
    • Ye, L.1    Lewis-Russell, J.M.2    Kynaston, H.3    Jiang, W.G.4
  • 17
    • 0036133374 scopus 로고    scopus 로고
    • Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells
    • Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD, Franceschi RT. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res 2002;17:101-110.
    • (2002) J Bone Miner Res , vol.17 , pp. 101-110
    • Xiao, G.1    Gopalakrishnan, R.2    Jiang, D.3    Reith, E.4    Benson, M.D.5    Franceschi, R.T.6
  • 18
    • 0031834165 scopus 로고    scopus 로고
    • Relationship between serum levels of interleukin-6, tumor necrosis factor-alpha and bone turnover markers in prostate cancer patients
    • Akimoto S, Okumura A, Fuse H. Relationship between serum levels of interleukin-6, tumor necrosis factor-alpha and bone turnover markers in prostate cancer patients. Endocr J 1998;45: 183-189.
    • (1998) Endocr J , vol.45 , pp. 183-189
    • Akimoto, S.1    Okumura, A.2    Fuse, H.3
  • 19
    • 0035667565 scopus 로고    scopus 로고
    • Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis
    • Shariat SF, Andrews B, Kattan MW, Kim J, Wheeler TM, Slawin KM. Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis. Urology 2001;58:1008-1015.
    • (2001) Urology , vol.58 , pp. 1008-1015
    • Shariat, S.F.1    Andrews, B.2    Kattan, M.W.3    Kim, J.4    Wheeler, T.M.5    Slawin, K.M.6
  • 20
    • 0037053394 scopus 로고    scopus 로고
    • Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts
    • Vermes C, Jacobs JJ, Zhang J, Firneisz G, Roebuck KA, Glant TT. Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts. J Biol Chem 2002;277:16879-16887.
    • (2002) J Biol Chem , vol.277 , pp. 16879-16887
    • Vermes, C.1    Jacobs, J.J.2    Zhang, J.3    Firneisz, G.4    Roebuck, K.A.5    Glant, T.T.6
  • 22
    • 0028224940 scopus 로고
    • Expression of monocyte chemoattractant protein 1 in human osteoblastic cells stimulated by proinflammatory mediators
    • Zhu JF, Valente AJ, Lorenzo JA, Carnes D, Graves DT. Expression of monocyte chemoattractant protein 1 in human osteoblastic cells stimulated by proinflammatory mediators. J Bone Miner Res 1994;9:1123-1130.
    • (1994) J Bone Miner Res , vol.9 , pp. 1123-1130
    • Zhu, J.F.1    Valente, A.J.2    Lorenzo, J.A.3    Carnes, D.4    Graves, D.T.5
  • 23
    • 0037105542 scopus 로고    scopus 로고
    • IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae
    • Palmqvist P, Persson E, Conaway HH, Lerner UH. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. J Immunol 2002;169:3353-3362.
    • (2002) J Immunol , vol.169 , pp. 3353-3362
    • Palmqvist, P.1    Persson, E.2    Conaway, H.H.3    Lerner, U.H.4
  • 24
  • 25
    • 0025630163 scopus 로고
    • Molecular cloning and expression of an IL-6 signal transducer, gp130
    • Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 1990;63:1149-1157.
    • (1990) Cell , vol.63 , pp. 1149-1157
    • Hibi, M.1    Murakami, M.2    Saito, M.3    Hirano, T.4    Taga, T.5    Kishimoto, T.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.